Kaitlin Ugolik Axovant’s Vivek Ramaswamy Aims to Reinvent Dementia Treatment In the wake of a record-breaking IPO, the CEO of the Alzheimer’s drug maker envisions treating cognitive decline like any other chronic disease. Kaitlin Ugolik September 8, 2015